Prenatal diagnosis of hemoglobin disorders: Present and future strategies

Clinical Biochemistry

Volumn 42, Issue 18, 2009, Pages 1767-1779

  Harteveld, Cornelis L ^a   Kleanthous, Marina ^b   Traeger Synodinos, Joanne ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Hemoglobinopathies; Non invasive prenatal diagnosis; Preimplantation genetic diagnosis; Prenatal diagnosis; Thalassemia

Indexed keywords

BETA THALASSEMIA; CLINICAL ASSESSMENT TOOL; DENATURING GRADIENT GEL ELECTROPHORESIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA DETERMINATION; DNA HYBRIDIZATION; DNA SEQUENCE; GENE AMPLIFICATION; GENE MUTATION; HEMOGLOBINOPATHY; HUMAN; INFERTILITY THERAPY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MULTIPLEX POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW;

DNA; FEMALE; HEMOGLOBINOPATHIES; HUMANS; MUTATION; PREGNANCY; PREIMPLANTATION DIAGNOSIS; PRENATAL DIAGNOSIS;

EID: 70449698144     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.07.001     Document Type: Review

References (114)

1. Kan Y.W., and Dozy A.M. Antenatal diagnosis of sickle-cell anaemia by D.N.A. analysis of amniotic-fluid cells. Lancet 2 (1978) 910-912
2. Gaziev J., Sodani P., and Lucarelli G. Hematopoietic stem cell transplantation in thalassemia. Bone. Marrow. Transplant. 42 Suppl. 1 (2008) S41
3. Sadelain M., Boulad F., Lisowki L., Moi P., and Riviere I. Stem cell engineering for the treatment of severe hemoglobinopathies. Curr. Mol. Med. 8 (2008) 690-697
4. Tabor A., Philip J., Madsen M., Bang J., Obel E.B., and Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1 (1986) 1287-1293
5. Hahn S., and Chitty L.S. Noninvasive prenatal diagnosis: current practice and future perspectives. Curr. Opin. Obstet. Gynecol. 20 (2008) 146-151
6. Handyside A.H., Kontogianni E.H., Hardy K., and Winston R.M. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 344 (1990) 768-770
7. Kanavakis E., and Traeger-Synodinos J. Preimplantation genetic diagnosis in clinical practice. J. Med. Genet. 39 (2002) 6-11
8. Renwick P., and Ogilvie C.M. Preimplantation genetic diagnosis for monogenic diseases: overview and emerging issues. Expert. Rev. Mol. Diagn. 7 (2007) 33-43
9. Thornhill A.R., deDie-Smulders C.E., Geraedts J.P., Harper J.C., Harton G.L., Lavery S.A., et al. ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)'. Hum. Reprod. 20 (2005) 35-48
10. Practice Committee of Society for Assisted Reproductive Technology; Practice Committee of American Society for Reproductive Medicine. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril 2008;90:S136-43.
11. Old J.M. Screening and genetic diagnosis of haemoglobin disorders. Blood. Rev. 17 (2003) 43-53
12. Old J.M. Prevention of thalasaemia and other haemoglobin disorders. In: Glanello R., Eleftheriou A., Traeger-Synodinos J., Old J.M., Petrou M., and Angastiniotis M. (Eds). Prenatal Diagnosis Vol. 1 (2003)
13. Decorte R., Cuppens H., Marynen P., and Cassiman J.J. Rapid detection of hypervariable regions by the polymerase chain reaction technique. DNA. Cell. Biol. 9 (1990) 461-469
14. Ristaldi M.S., Pirastu M., Rosatelli C., Monni G., Erlich H., Saiki R., et al. Prenatal diagnosis of beta-thalassaemia in Mediterranean populations by dot blot analysis with DNA amplification and allele specific oligonucleotide probes. Prenat. Diagn. 9 (1989) 629-638
15. Saiki R.K., Walsh P.S., Levenson C.H., and Erlich H.A. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6230-6234
16. Maggio A., Giambona A., Cai S.P., Wall J., Kan Y.W., and Chehab F.F. Rapid and simultaneous typing of hemoglobin S, hemoglobin C, and seven Mediterranean beta-thalassemia mutations by covalent reverse dot-blot analysis: application to prenatal diagnosis in Sicily. Blood 81 (1993) 239-242
17. Sutcharitchan P., Saiki R., Fucharoen S., Winichagoon P., Erlich H., and Embury S.H. Reverse dot-blot detection of Thai beta-thalassaemia mutations. Br. J. Haematol. 90 (1995) 809-816
18. Sutcharitchan P., Saiki R., Huisman T.H., Kutlar A., McKie V., Erlich H., et al. Reverse dot-blot detection of the African-American beta-thalassemia mutations. Blood 86 (1995) 1580-1585
19. Winichagoon P., Saechan V., Sripanich R., Nopparatana C., Kanokpongsakdi S., Maggio A., et al. Prenatal diagnosis of beta-thalassaemia by reverse dot-blot hybridization. Prenat. Diagn. 19 (1999) 428-435
20. Gemignani F., Perra C., Landi S., Canzian F., Kurg A., Tonisson N., et al. Reliable detection of beta-thalassemia and G6PD mutations by a DNA microarray. Clin. Chem. 48 (2002) 2051-2054
21. Bang-Ce Y., Hongqiong L., Zhuanfong Z., Zhengsong L., and Jianling G. Simultaneous detection of alpha-thalassemia and beta-thalassemia by oligonucleotide microarray. Haematologica 89 (2004) 1010-1012
22. Cremonesi L., Ferrari M., Giordano P.C., Harteveld C.L., Kleanthous M., Papasavva T., et al. An overview of current microarray-based human globin gene mutation detection methods. Hemoglobin 31 (2007) 289-311
23. Newton C.R., Graham A., Heptinstall L.E., Powell S.J., Summers C., Kalsheker N., et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17 (1989) 2503-2516
24. Tan J.A., Tay J.S., Lin L.I., Kham S.K., Chia J.N., Chin T.M., et al. The amplification refractory mutation system (ARMS): a rapid and direct prenatal diagnostic technique for beta-thalassaemia in Singapore. Prenat. Diagn. 14 (1994) 1077-1082
25. Tan A.S., Quah T.C., Low P.S., and Chong S.S. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alpha-thalassemia. Blood 98 (2001) 250-251
26. Chong S.S., Boehm C.D., Higgs D.R., and Cutting G.R. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 95 (2000) 360-362
27. Liu Y.T., Old J.M., Miles K., Fisher C.A., Weatherall D.J., and Clegg J.B. Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br. J. Haematol. 108 (2000) 295-299
28. Old J.M., Varawalla N.Y., and Weatherall D.J. Rapid detection and prenatal diagnosis of beta-thalassaemia: studies in Indian and Cypriot populations in the UK. Lancet 336 (1990) 834-837
29. Craig J.E., Barnetson R.A., Prior J., Raven J.L., and Thein S.L. Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification. Blood 83 (1994) 1673-1682
30. Myers R.M., Maniatis T., and Lerman L.S. Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol. 155 (1987) 501-527
31. Fodde R., and Losekoot M. Mutation detection by denaturing gradient gel electrophoresis (DGGE). Hum. Mutat. 3 (1994) 83-94
32. Losekoot M., Fodde R., Harteveld C.L., van Heeren H., Giordano P.C., and Bernini L.F. Denaturing gradient gel electrophoresis and direct sequencing of PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassaemia. Br. J. Haematol. 76 (1990) 269-274
33. O'Donovan M.C., Oefner P.J., Roberts S.C., Austin J., Hoogendoorn B., Guy C., et al. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 52 (1998) 44-49
34. Li Q., Li L.Y., Huang S.W., Li L., Chen X.W., Zhou W.J., et al. Rapid genotyping of known mutations and polymorphisms in beta-globin gene based on the DHPLC profile patterns of homoduplexes and heteroduplexes. Clin. Biochem. 41 (2008) 681-687
35. Su Y.N., Lee C.N., Hung C.C., Chen C.A., Cheng W.F., Tsao P.N., et al. Rapid detection of beta-globin gene (HBB) mutations coupling heteroduplex and primer-extension analysis by DHPLC. Hum. Mutat. 22 (2003) 326-336
36. Colosimo A., Guida V., Scolari A., De Luca A., Palka G., Rigoli L., et al. Validation of dHPLC for molecular diagnosis of beta-thalassemia in Southern Italy. Genet. Test. 7 (2003) 269-275
37. Thein S.L., Hesketh C., Brown J.M., Anstey A.V., and Weatherall D.J. Molecular characterization of a high A2 beta thalassemia by direct sequencing of single strand enriched amplified genomic DNA. Blood 73 (1989) 924-930
38. Traeger-Synodinos JH, CL. Disease services: haemoglobinopathies, in Molecular Diagnosis of Genetic Disease. In: Elles R, Wallace A, ed., Vol., in press.
39. Schouten J.P., McElgunn C.J., Waaijer R., Zwijnenburg D., Diepvens F., and Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30 (2002) e57
40. White S.J., Vink G.R., Kriek M., Wuyts W., Schouten J., Bakker B., et al. Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses. Hum. Mutat. 24 (2004) 86-92
41. Harteveld C.L., Voskamp A., Phylipsen M., Akkermans N., den Dunnen J.T., White S.J., et al. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J. Med. Genet. 42 (2005) 922-931
42. Harteveld C.L., Kriek M., Bijlsma E.K., Erjavec Z., Balak D., Phylipsen M., et al. Refinement of the genetic cause of ATR-16. Hum. Genet. 122 (2007) 283-292
43. Charbonnier F., Raux G., Wang Q., Drouot N., Cordier F., Limacher J.M., et al. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer. Res. 60 (2000) 2760-2763
44. Ferec C., Casals T., Chuzhanova N., Macek Jr. M., Bienvenu T., Holubova A., et al. Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms. Eur. J. Hum. Genet. 14 (2006) 567-576
45. Gouas L., Goumy C., Veronese L., Tchirkov A., and Vago P. Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities. Pathol. Biol. (Paris) 56 (2008) 345-353
46. Saugier-Veber P., Goldenberg A., Drouin-Garraud V., de La Rochebrochard C., Layet V., Drouot N., et al. Simple detection of genomic microdeletions and microduplications using QMPSF in patients with idiopathic mental retardation. Eur. J. Hum. Genet. 14 (2006) 1009-1017
47. Rose C., Rossignol J., Lambilliotte A., Depret S., Le Metayer N., and Pissard S. A novel (epsilongammadeltabeta)(o)-thalassemia deletion associated with an alpha globin gene triplication leading to a severe transfusion dependent fetal thalassemic syndrome. Haematologica 94 (2009) 593-594
48. Vrettou C., Traeger-Synodinos J., Tzetis M., Malamis G., and Kanavakis E. Rapid screening of multiple beta-globin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. Clin. Chem. 49 (2003) 769-776
49. Costa C., Pissard S., Girodon E., Huot D., and Goossens M. A one-step real-time PCR assay for rapid prenatal diagnosis of sickle cell disease and detection of maternal contamination. Mol. Diagn. 7 (2003) 45-48
50. Reed G.H., Kent J.O., and Wittwer C.T. High-resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics 8 (2007) 597-608
51. Wittwer C.T., Reed G.H., Gundry C.N., Vandersteen J.G., and Pryor R.J. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin. Chem. 49 (2003) 853-860
52. Herrmann M.G., Durtschi J.D., Bromley L.K., Wittwer C.T., and Voelkerding K.V. Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes. Clin. Chem. 52 (2006) 494-503
53. Herrmann M.G., Durtschi J.D., Bromley L.K., Wittwer C.T., and Voelkerding K.V. Instrument comparison for heterozygote scanning of single and double heterozygotes: a correction and extension of Herrmann et al. Clin. Chem. 52 (2006) 494-503 Clin Chem 2007;53:150-2.
54. Prathomtanapong P., Pornprasert S., Phusua A., Suanta S., Saetung R., and Sanguansermsri T. Detection and identification of beta-thalassemia 3.5 kb deletion by SYBR Green1 and high resolution melting analysis. Eur. J. Haematol. 82 (2009) 159-160
55. Zhou L., Myers A.N., Vandersteen J.G., Wang L., and Wittwer C.T. Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye. Clin. Chem. 50 (2004) 1328-1335
56. Colosimo A., Guida V., De Luca A., Cappabianca M.P., Bianco I., Palka G., et al. Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles. Hum. Mutat. 19 (2002) 287-295
57. Pornprasert S., Sukunthamala K., Sacome J., Phusua A., Saetung R., Sanguansermsri T., et al. Analysis of real-time SYBR-polymerase chain reaction cycle threshold for diagnosis of the alpha-thalassemia-1 Southeast Asian type deletion: application to carrier screening and prenatal diagnosis of Hb Bart's hydrops fetalis. Hemoglobin 32 (2008) 393-402
58. Gundry C.N., Vandersteen J.G., Reed G.H., Pryor R.J., Chen J., and Wittwer C.T. Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes. Clin. Chem. 49 (2003) 396-406
59. Liew M., Pryor R., Palais R., Meadows C., Erali M., Lyon E., et al. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin. Chem. 50 (2004) 1156-1164
60. Herrmann M.G., Dobrowolski S.F., and Wittwer C.T. Rapid beta-globin genotyping by multiplexing probe melting temperature and color. Clin. Chem. 46 (2000) 425-428
61. Goossens V., Harton G., Moutou C., Scriven P.N., Traeger-Synodinos J., Sermon K., et al. ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006. Hum. Reprod. 23 (2008) 2629-2645
62. Goossens V, Harton G, Moutou C, Traeger-Synodinos J, Van Rij M, Harper JC. ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007 Hum Reprod 2009;24:1786-810.
63. Wilton L., Thornhill A., Traeger-Synodinos J., Sermon K.D., and Harper J.C. The causes of misdiagnosis and adverse outcomes in PGD. Hum. Reprod. (2009)
64. Spits C., and Sermon K. PGD for monogenic disorders: aspects of molecular biology. Prenat. Diagn. 29 (2009) 50-56
65. Kuliev A., Rechitsky S., Verlinsky O., Ivakhnenko V., Evsikov S., Wolf G., et al. Preimplantation diagnosis of thalassemias. J. Assist. Reprod. Genet. 15 (1998) 219-225
66. Vrettou C., Palmer G., Kanavakis E., Tzetis M., Antoniadi T., Mastrominas M., et al. A widely applicable strategy for single cell genotyping of beta-thalassaemia mutations using DGGE analysis: application to preimplantation genetic diagnosis. Prenat. Diagn. 19 (1999) 1209-1216
67. De Rycke M., Van de Velde H., Sermon K., Lissens W., De Vos A., Vandervorst M., et al. Preimplantation genetic diagnosis for sickle-cell anemia and for beta-thalassemia. Prenat. Diagn. 21 (2001) 214-222
68. Piyamongkol W., Harper J.C., Delhanty J.D., and Wells D. Preimplantation genetic diagnostic protocols for alpha- and beta-thalassaemias using multiplex fluorescent PCR. Prenat. Diagn. 21 (2001) 753-759
69. Fiorentino F., Magli M.C., Podini D., Ferraretti A.P., Nuccitelli A., Vitale N., et al. The minisequencing method: an alternative strategy for preimplantation genetic diagnosis of single gene disorders. Mol. Hum. Reprod. 9 (2003) 399-410
70. Vrettou C., Traeger-Synodinos J., Tzetis M., Palmer G., Sofocleous C., and Kanavakis E. Real-time PCR for single-cell genotyping in sickle cell and thalassemia syndromes as a rapid, accurate, reliable, and widely applicable protocol for preimplantation genetic diagnosis. Hum. Mutat. 23 (2004) 513-521
71. Edwards R.G. Ethics of PGD: thoughts on the consequences of typing HLA in embryos. Reprod. Biomed. Online. 9 (2004) 222-224
72. Fiorentino F., Biricik A., Karadayi H., Berkil H., Karlikaya G., Sertyel S., et al. Development and clinical application of a strategy for preimplantation genetic diagnosis of single gene disorders combined with HLA matching. Mol. Hum. Reprod. 10 (2004) 445-460
73. Van de Velde H., Georgiou I., De Rycke M., Schots R., Sermon K., Lissens W., et al. Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum. Reprod. 19 (2004) 700-708
74. Kuliev A., Rechitsky S., Verlinsky O., Tur-Kaspa I., Kalakoutis G., Angastiniotis M., et al. Preimplantation diagnosis and HLA typing for haemoglobin disorders. Reprod. Biomed. Online. 11 (2005) 362-370
75. Qureshi N., Foote D., Walters M.C., Singer S.T., Quirolo K., and Vichinsky E.P. Outcomes of preimplantation genetic diagnosis therapy in treatment of beta-thalassemia: a retrospective analysis. Ann. N.Y. Acad. Sci. 1054 (2005) 500-503
76. Schroder J. Transplacental passage of blood cells. J. Med. Genet. 12 (1975) 230-242
77. Lo Y.M., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350 (1997) 485-487
78. Bianchi D.W., Flint A.F., Pizzimenti M.F., Knoll J.H., and Latt S.A. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3279-3283
79. Cheung M.C., Goldberg J.D., and Kan Y.W. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat. Genet. 14 (1996) 264-268
80. Kolialexi A., Vrettou C., Traeger-Synodinos J., Burgemeister R., Papantoniou N., Kanavakis E., et al. Noninvasive prenatal diagnosis of beta-thalassaemia using individual fetal erythroblasts isolated from maternal blood after enrichment. Prenat. Diagn. 27 (2007) 1228-1232
81. Bianchi D.W. Fetal cells in the maternal circulation: feasibility for prenatal diagnosis. Br. J. Haematol. 105 (1999) 574-583
82. Alberry M., Maddocks D., Jones M., Abdel Hadi M., Abdel-Fattah S., Avent N., et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat. Diagn. 27 (2007) 415-418
83. Lo Y.M., Zhang J., Leung T.N., Lau T.K., Chang A.M., and Hjelm N.M. Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet. 64 (1999) 218-224
84. Chan K.C., Zhang J., Hui A.B., Wong N., Lau T.K., Leung T.N., et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin. Chem. 50 (2004) 88-92
85. Li Y., Zimmermann B., Rusterholz C., Kang A., Holzgreve W., and Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin. Chem. 50 (2004) 1002-1011
86. Lo Y.M., Hjelm N.M., Fidler C., Sargent I.L., Murphy M.F., Chamberlain P.F., et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N. Engl. J. Med. 339 (1998) 1734-1738
87. Lun F.M., Chiu R.W., Allen Chan K.C., Yeung Leung T., Kin Lau T., and Dennis Lo Y.M. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin. Chem. 54 (2008) 1664-1672
88. Zimmermann B.G., Maddocks D.G., and Avent N.D. Quantification of circulatory fetal DNA in the plasma of pregnant women. Methods. Mol. Biol. 444 (2008) 219-229
89. Purwosunu Y., Sekizawa A., and Okai T. Detection and quantification of fetal DNA in maternal plasma by using LightCycler technology. Methods. Mol. Biol. 444 (2008) 231-238
90. Amicucci P., Gennarelli M., Novelli G., and Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin. Chem. 46 (2000) 301-302
91. Chiu R.W., Lau T.K., Leung T.N., Chow K.C., Chui D.H., and Lo Y.M. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 360 (2002) 998-1000
92. Chen C.P., Chern S.R., and Wang W. Fetal DNA analyzed in plasma from a mother's three consecutive pregnancies to detect paternally inherited aneuploidy. Clin. Chem. 47 (2001) 937-939
93. Costa J.M., Benachi A., and Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N. Engl. J. Med. 346 (2002) 1502
94. Finning K.M., Martin P.G., Soothill P.W., and Avent N.D. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42 (2002) 1079-1085
95. Zhong X.Y., Holzgreve W., and Hahn S. Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss. Med. Wkly. 131 (2001) 70-74
96. Bustamante-Aragones A., Gallego-Merlo J., Trujillo-Tiebas M.J., de Alba M.R., Gonzalez-Gonzalez C., Glover G., et al. New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma. J. Cyst. Fibros. 7 (2008) 505-510
97. Ding C., Chiu R.W., Lau T.K., Leung T.N., Chan L.C., Chan A.Y., et al. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10762-10767
98. Fucharoen G., Tungwiwat W., Ratanasiri T., Sanchaisuriya K., and Fucharoen S. Prenatal detection of fetal hemoglobin E gene from maternal plasma. Prenat. Diagn. 23 (2003) 393-396
99. Galbiati S., Foglieni B., Travi M., Curcio C., Restagno G., Sbaiz L., et al. Peptide-nucleic acid-mediated enriched polymerase chain reaction as a key point for non-invasive prenatal diagnosis of beta-thalassemia. Haematologica 93 (2008) 610-614
100. Gonzalez-Gonzalez M.C., Garcia-Hoyos M., Trujillo M.J., Rodriguez de Alba M., Lorda-Sanchez I., Diaz-Recasens J., et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat. Diagn. 22 (2002) 946-948
101. Gonzalez-Gonzalez M.C., Trujillo M.J., Rodriguez de Alba M., and Ramos C. Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR. Neurology 60 (2003) 1214-1215
102. Li Y., Holzgreve W., Page-Christiaens G.C., Gille J.J., and Hahn S. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma-case report. Prenat. Diagn. 24 (2004) 896-898
103. Lun F.M., Tsui N.B., Chan K.C., Leung T.Y., Lau T.K., Charoenkwan P., et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 19920-19925
104. Nasis O., Thompson S., Hong T., Sherwood M., Radcliffe S., Jackson L., et al. Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis. Clin. Chem. 50 (2004) 694-701
105. Papasavva T., Kalikas I., Kyrri A., and Kleanthous M. Arrayed primer extension for the noninvasive prenatal diagnosis of beta-thalassemia based on detection of single nucleotide polymorphisms. Ann. N. Y. Acad. Sci. 1137 (2008) 302-308
106. Saito H., Sekizawa A., Morimoto T., Suzuki M., and Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 356 (2000) 1170
107. Ding C. Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma. Methods. Mol. Biol. 444 (2008) 253-267
108. Li Y., Di Naro E., Vitucci A., Zimmermann B., Holzgreve W., and Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 293 (2005) 843-849
109. Galbiati S., Foglieni B., Travi M., Curcio C., Restagno G., Sbaiz L., et al. Peptide-nucleic acid-mediated enriched polymerase chain reaction as a key point for non-invasive prenatal diagnosis of {beta}-thalassemia. Haematologica 93 (2008) 610-614
110. Kurg A., Tonisson N., Georgiou I., Shumaker J., Tollett J., and Metspalu A. Arrayed primer extension: solid-phase four-color DNA resequencing and mutation detection technology. Genet. Test. 4 (2000) 1-7
111. Lun F.M.F., Chiu R.W.K., Allen Chan K.C., Yeung Leung T., Kin Lau T., and Dennis Lo Y.M. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin. Chem. 54 (2008) 1664-1672
112. Zimmermann B.G., Grill S., Holzgreve W., Zhong X.Y., Jackson L.G., and Hahn S. Digital PCR: a powerful new tool for noninvasive prenatal diagnosis?. Prenat. Diagn. 28 (2008) 1087-1093
113. Maddocks D.G., Alberry M.S., Attilakos G., Madgett T.E., Choi K., Soothill P.W., et al. The SAFE project: towards non-invasive prenatal diagnosis. Biochem. Soc. Trans. 37 (2009) 460-465
114. Chitty L.S., van der Schoot C.E., Hahn S., and Avent N.D. SAFE-the Special Non-invasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements. Prenat. Diagn. 28 (2008) 83-88